Christianson Mark 4
4 · NEUROONE MEDICAL TECHNOLOGIES Corp · Filed Mar 12, 2026
Research Summary
AI-generated summary of this filing
NeuroOne (NMTC) Business Dev Director Mark Christianson Sells Shares
What Happened
Mark Christianson, Business Development Director at NeuroOne Medical Technologies (NMTC), sold a total of 13,720 shares in two open-market transactions: 11,611 shares on 2026-03-10 for about $9,289 and 2,109 shares on 2026-03-11 for about $1,687 — roughly $10,976 in proceeds. These were sales (not purchases), which are often routine insider liquidity events rather than an explicit signal about the company.
Key Details
- Transaction dates and prices:
- 2026-03-10: 11,611 shares sold, weighted avg price reported $0.80 (range $0.80–$0.8102 per F1).
- 2026-03-11: 2,109 shares sold, weighted avg price reported $0.80 (range $0.80–$0.805 per F2).
- Total shares sold: 13,720; total reported proceeds ≈ $10,976.
- Shares owned after the transaction: Not specified in the provided filing.
- Footnotes: F1 and F2 state the reported prices are weighted averages of multiple transactions and list the price ranges; the reporting person will provide a per-price breakdown to the SEC on request.
- Timeliness: Form 4 filed 2026-03-12 for transactions on 2026-03-10 and 2026-03-11; filing appears timely (no late filing indicated).
Context
This filing documents outright open-market sales by a company officer. Sales are common for personal liquidity or portfolio reasons and do not by themselves indicate management’s view of company fundamentals. The amounts here are modest (~$11k total).
Insider Transaction Report
- Sale
Common Stock
[F1]2026-03-10$0.80/sh−11,611$9,289→ 217,309 total - Sale
Common Stock
[F2]2026-03-11$0.80/sh−2,109$1,687→ 215,200 total
Footnotes (2)
- [F1]The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $0.80 and 0.8102 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.
- [F2]The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $0.80 and 0.805 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.